Guide

A cheap 409A is fine. A careless one is expensive

Updated

Price is not the 409A risk: statute sets the standard. The risk is failing IRS and auditor tests, checkable before buying; the cheapest answers them more clearly than the dearest.

Talk to a specialist

What safe harbour actually requires

Section 409A presumes a valuation reasonable where qualified independent appraisers do it, for an illiquid startup's common stock. It must be no more than twelve months old with no material event since. If the presumption holds, the burden shifts: the IRS has to show the valuation was grossly unreasonable, not you that it was right.

That is what you are buying. A cheap report that meets those conditions carries the same presumption as an expensive one.

The four things worth checking

Who signs it. Eqvista states its valuations are performed by NACVA certified valuation analysts, the only appraiser qualification named on any pricing page in this comparison.

Whether audit support is included and for how long. Eqvista states lifetime audit support for every valuation. That matters because the report is challenged, if it ever is, years after you bought it and long after the relationship has gone quiet.

Whether the report is described as audit-ready or audit-defensible. Cake Equity states an audit-ready 409A on Team and audit-ready reporting for Series A and B+ on Pro. Pulley and Fidelity Private Shares make no such claim on their pricing pages. That is not evidence of a worse report, but a gap in what you can check beforehand.

What happens on a raise. The valuation you bought in January is void the day a priced round closes, so ask what the refresh costs before you need one.

Where cheap genuinely goes wrong

Not in the arithmetic, which is largely conventional, but in two places. The first is a report that will not survive your auditor's questions about method and inputs, which is why appraiser qualification and audit support are worth more than a discount.

The second is timing. A valuation that arrives after you have already granted options does not retrospectively protect those grants. Speed and price trade off directly here, and the expedite fee is the honest price of having left it late.

What none of them publish

Three things are absent from every pricing page we read. None publishes what a refresh costs outside its bundle. None publishes what happens if your auditor rejects the report. And only one publishes a turnaround time at all.

Get all three in writing before you sign, whichever route you take. They are the questions a 409A provider can answer in a sentence, and a vague answer to any of them is itself informative.

Want quotes for a 409A at your stage?

Tell us your funding stage and whether you expect to raise this year. Those two answers decide whether a standalone subscription or a bundled plan is cheaper, and providers that fit will quote you directly.

Next: where to reach you.

  • Free, no obligation
  • No commission taken on any provider
  • Priced on your stage, not a generic quote

Sources

This site's own datasets, every figure quoted from its source and dated:

  • The 409A Price Index carries 21 published figures read from 12 sources' own pages; the 11 published figures given without a breakdown run from 499 to 2,000 USD, read 11 November 2026.
  • The median published figure in the 409A Provider Board is 500 USD across 5 figures from 3 sources' own pages (range 175 to 1,500 USD), read 11 November 2026.
  • The 409A Safe Harbor Rules carries 5 published figures read from 3 sources' own pages, from 1 to 50 percent, read 7 November 2026.
  1. Eqvista, 409A valuation pricing
  2. Eqvista, pricing
  3. Cake Equity, pricing
  4. Pulley, pricing
  5. Fidelity Private Shares, pricing

Compare the route, not the headline

Four US providers, three completely different ways of selling the same statutory report, and the refresh policy that decides what a year of it really costs.

Talk to a specialist